Related Experiment Videos
[Drug-induced and toxic myopathies]
M Coquet1, B Bannwarth, D Henin
1Service d'anatomie pathologique et de neuropathologie, groupe hospitalier Pellegrin 33076 Bordeaux. michelle.coquet@chu.bordeaux.fr
La Revue Du Praticien
|March 27, 2001
Summary
Toxic myopathies, induced by various drugs and toxins, are common and present diverse pathological mechanisms. Early diagnosis and agent discontinuation are crucial for reversibility and preventing severe outcomes.
Area of Science:
- Neurology
- Toxicology
- Pathology
Context:
- Drugs and toxins are frequently implicated in causing myopathic changes.
- The prevalence of toxic myopathies may be underestimated in clinical practice.
Purpose:
- To categorize the main types of toxic myopathies based on their pathological mechanisms.
- To highlight the importance of recognizing and diagnosing drug-induced myopathies.
Summary:
- Six main categories of toxic myopathies are identified: necrotizing, vacuolar, inflammatory, mitochondrial, steroid, and hypokalemic.
- Clinical and pathological features vary depending on the causative agent and individual susceptibility.
- Muscle biopsy is a valuable diagnostic tool for toxic myopathies.
Impact:
- Prompt identification and cessation of the offending agent can lead to reversible myopathic changes.
- Timely diagnosis can mitigate damaging effects and prevent potentially fatal outcomes associated with toxic myopathies.